• Home
  • Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer.

Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer.

Author List
Sahoo D, Wei W, Auman H, Hurtado-Coll A, Carroll PR, Fazli L, Gleave ME, Lin DW, Nelson PS, Simko J, Thompson IM, Leach RJ, Troyer DA, True LD, McKenney JK, Feng Z, Brooks JD
Publication
Oncotarget
Publication ID (Profile URL)
https://researcherprofiles.org/profile/14387992
Publication Year
2018
PubMed ID
29464091
Publication Title
Sahoo D, Wei W, Auman H, Hurtado-Coll A, Carroll PR, Fazli L, Gleave ME, Lin DW, Nelson PS, Simko J, Thompson IM, Leach RJ, Troyer DA, True LD, McKenney JK, Feng Z, Brooks JD. Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer. Oncotarget. 2018 Jan 19; 9(5):6550-6561.